Remedy, the studio behind games like Alan Wake and Quantum Break, are moving forward with its mysterious new game, codenamed "P7." The project, according to a recent earnings report from the company, is expected to release in 2019. In the meantime, Remedy's new, multi-project model means that a new project has entered preliminary preparations.
We've known about "P7" for some time. Based on Remedy's own website which lists P7 as a "cinematic third-person action game set in a new Remedy-created universe," we know that P7 isn't likely a sequel to an existing Remedy IP.
In addition, job listings for the project suggested that Destiny-like online might be included as Remedy was looking for a Game Designer of World Systems that can design systems that can "keep players engaged and the community buzzing." The studio even tweeted at Hangar 13 staff who were hit by the recent layoffs to Remedy's own job openings.
P7 is one of the three projects we know Remedy is working on currently. The studio is also working on the story mode for Crossfire 2 with South Korean company Smilegate. Remedy's contributions are only a part of Crossfire 2, as opposed to the in-house P7.
However, aside from the two games, is a third, unannounced title that according to the earnings report has just entered preparations at the end of 2017. So it'll likely be some time before we hear anything about this new game.
Remedy most recently worked with Microsoft to launch Quantum Break on the Xbox One. The game was an early Xbox One exclusive which brought in Remedy's trademark cinematic, third-person action adventure to the console. That style of gameplay and storytelling hasn't changed, though it seems as though Remedy is interested in building out multiplayer in later titles.
The partnership with 505 Games, which previously published games like Payday 2 and Rocket League, also means that P7 will not be a Xbox One exclusive, but will be available across platforms including PS4 and PC.
This article may contain links to online retail stores. If you click on one and buy the product we may receive a small commission. For more information, go here.